Abstract
Induction of donor-specific tolerance would be desirable and might even be essential to the success of clinical xenotransplantation for several reasons:
-
1.
It would eliminate the risk of acute or chronic rejection. Chronic rejection currently leads to eventual graft loss in a high percentage of allograft recipients, despite recent improvements in immunosuppressive therapy. In view of the frequently greater difficulty that is encountered in attenuating xenoresponses than alloresponses [1], it seems likely that both acute and chronic rejection might be a major limitation to xenogeneic organ transplantation, even if the initial natural antibody-induced hyperacute rejection problem could be overcome.
-
2.
A state of tolerance would obviate the need for chronic imunosuppressive therapy with its attendant risks of opportunistic infection, malignancy and organ toxicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Auchincloss HA. Why is cell-mediated xenograft rejection so strong? Xeno 1995, 3: 19
Billingham RE, Brent L, Medawar PB. “Actively acquired tolerance” of foreign cells. Nature 1953, 172: 603
Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984, 307(5947): 168
Sykes M, Sheard M, Sachs DH. Effects of T cell depletion in radiation bone marrow chimeras. I Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD. J Immunol 1988, 141: 2282
Mar rack P, Lo D, Brinster R, et al. The effect of thymus environment on T cell development and tolerance. Cell 1988, 53: 627
Slavin S. Total lymphoid irradiation. Immunol Today 1987, 3: 88
Pierce GE. Allogeneic versus semiallogeneic Fi bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity. Transplantation 1990, 49: 138
Mayumi H, Good RA. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J Exp Med 1989,169: 213
Clift RA, Storb R. Histoincompatible bone marrow transplants in humans. Ann Rev Immunol 1987, 5: 43
O’Reilly RJ, Collins NH, Kernan N, et al. Transplantation of marrow depleted of T cells by soybean lectin agglutination and E-rosette depletion: major histocompatibility complex-related graft resistance in leukemic transplant recipients. Transplant Proc 1985, 17: 455
Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989, 320: 197
Ildstad ST, Wren SM, Sharrow SO, Stephany D, Sachs DH. In vivo and in vitro characterization of specific hyporeactivity to skin xenografts in mixed xenogeneically reconstituted mice (B10+ F344 rat→B10). J Exp Med 1984, 160: 1820
Santos GW, Cole LJ. Effects of donor and host lymphoid and myeloid tissue injections in lethally X-irradiated mice treated with rat bone marrow. J Natl Cancer Inst 1958, 21: 279
Bau J, Thierfelder S. Antilymphocytic antibodies and marrow transplantation. Transplantation 1973, 15: 564
Muller-Rucholtz W, Muller-Hermelink HK, Wottge HU. Induction of lasting hematopoietic chimerism in a xenogeneic (rat → mouse) model. Transplant Proc 1979, 11: 517
Deeg HJ, Storb R, Thomas ED. Bone marrow transplantation: a review of delayed complications. Br J Haematol 1984, 57: 185
Freirich EJ, Gehan EA, Rail DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anti-cancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemotherapy Rep 1966, 50: 219
Sullivan K M, Witherspoon R P, Storb R, et al. Chronic graft-versus-host disease: recent advances in diagnosis and treatment. In: Gale R P, Champlin R, eds. Alan R. Liss, Inc., New York, 1989: 511
Makinodan T. Circulating rat cells in lethally irradiated mice protected with rat bone marrow. Proc Soc Exp Biol Med 1956, 92: 174
Gale RP, Reisner Y. Graft rejection and graft-versus-host disease: mirror images. Lancet 1986, i: 1468
Poynton CH. T cell depletion in bone marrow transplantation. Bone Marrow Transplant 1988, 3: 265
Martin PJ, Hansen JA, Buckner CD, et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985, 66: 664
Kernan NA, Flomenberg N, Dupont B, O’Reilly RJ. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Transplantation 1987, 43: 842
Soderling CCB, Song CW, Blazar BR, Vallera DA. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants. J Immunol 1985, 135: 941
Ferrara JLM, Lipton J, Hellman S, Burakoff S, Mauch P. Engraftment following T-cell-depleted marrow transplantation. Transplantation 1987, 43: 461
Zinkernagel RM, Callahan GN, Althage A, Cooper S, Klein PA, Klein J. On the thymus in the differentiation of “H-2 self-recognition” by T cells: evidence for dual recognition? J Exp Med 1978, 147: 882
Singer A, Hathcock KS, Hodes RJ. Self recognition in allogeneic radiation chimeras. A radiation resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells. J Exp Med 1981, 153: 1286
Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 1985, 162: 231
Zinkernagel RM, Althage A, Callahan G, Welsh Jr RM. On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J Immunol 1980, 124: 2356
Ruedi E, Sykes M, Ildstad ST, et al. Antiviral T cell competence and restriction specificty of mixed allogeneic (P1+P2 → Pi) irradiation chimeras. Cell Immuol 1989, 121: 185
Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 1989, 169: 493
Sharabi Y, Aksentijevich I, Sundt III TM, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990, 172: 195
Moretta L, Ciccone E, Moretta A, Hoglund P, Ohlen C, Karre K. Allorecognition by NK cells: nonself or no self? Immunol Today 1992, 13: 300
Bix M, Liao N-S, Zijlstra M, Loring J, Jaenisch R, Raulet D. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 1991, 349: 329
Salcedo M, Hoglund P, Ljunggren H-G. Natural killer cell interaction with murine allogeneic MHC class I molecules. Transplantation 1995, 60: 281
Yankelevich B, Knobloch C, Nowicki M, Dennert G. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts. J Immunol 1989, 142: 3423
Kikly K, Dennert G. Evidence for a role for T cell receptors (TCR) in the effector phase of acute bone marrow graft rejection. TCR Vb5 transgenic mice lack effector cells able to cause graft rejection. J Immunol 1992, 149: 3489
Takeda K, Moore MW, Dennert G. Acute rejection of marrow grafts in mice. Dependence on and independence of functional TCR in the rejection process. J Immunol 1994, 152: 4407
Okumura C, Suto R, Furukawa K, et al. Induction of murine gamma-delta T cells cytotoxic for xenogeneic rat cells. J Immunol 1995, 154: 1114
Tomita Y, Sachs DH, Khan A, Sykes M. Additional mAb injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation. Transplantation 1996, 61: 469
Tomita Y, Lee LA, Sykes M. Engraftment of rat bone marrow and its role in negative selection of murine T cells in mice conditioned with a modified non-myeloablative regimen. Xenotransplantation 1994, 1: 109
van Ewijk W, Ron Y, Monaco J, et al. Compartmentalization of MHC class II gene expression in transgenic mice. Cell 1988, 53: 357
Ramsdell F, Fowlkes BJ. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 1990, 248: 1342
Schonrich G, Strauss G, Muller K-P, et al. Distinct requirements of positive and negative selection for selecting cell type and CD8 interaction. J Immunol 1993, 151: 4098
Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantion in mice conditioned with a non-myeloablative regimen. J Immunol 1994, 153: 1087
Matzinger P, Guerder S. Does T cell tolerance require a dedicated antigen-presenting cell? Nature 1989, 338: 74
Inaba M, Inaba K, Hosono M, et al. Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells. J Exp Med 1991, 173: 549
Tomita Y, Khan A, Sykes M. Mechanism by which additional monoclonal antibody injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation. Transplantation 1996, 61: 477
Aksentijevich I, Sachs DH, Sykes M. Humoral tolerance in xenogeneic BMT recipients conditioned with a non-myeloablative regimen. Transplantation 1992, 53: 1108
Aksentijevich I, Sachs DH, Sykes M. Normal mouse serum contains natural antibody against bone marrow cells of a concordant xenogeneic species. J Immunol 1991, 147: 79
Aksentijevich I, Sachs DH, Sykes M. Natural antibodies can inhibit bone marrow engraftment in the rat → mouse species combination. J Immunol 1991, 147: 4140
Lee LA, Sergio JJ, Sachs DH, Sykes M. Mechanism of tolerance in mixed xenogeneic chimeras prepared with a non-myeloablative conditioning regimen. Transplant Proc 1994, 26: 1197
Latinne D, Vitiello D, Sachs DH, Sykes M. Tolerance to discordant xenografts: I. Human natural antibody determinants are shared on miniature swine bone marrow cells and endothelial cells. Transplantation 1994, 57: 238
Murakami M, Tsubata T, Okamoto M, et al. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 1992, 357: 77
Lee LA, Sergio JJ, Sykes M. Evidence for non-immune mechanisms in the loss of hematopoietic chimerism in rat → mouse mixed xenogeneic chimeras. Xenotransplantation 1995, 2: 57
Gritsch, H.A. and Sykes, M. Host morrow for a competitive advantage which limits donor hematopoietic repopulation in mixed xenogeneic chimeras. In press, Xenotransplantation
Taylor R. A pig in a poke? Xenotransplants and infectious disease. Nature Med 1995, 1: 728
Sachs D H. MHC-Homozygous miniature swine. In: Swindle M M, Moody D C, Phillips L D, eds. Iowa State University Press, Ames,IA, 1992: 3
Sachs DH, Leight G, Cone J, Schwarz S, Stuart L, Rosenberg S. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 1976, 22: 559
Schuler W, Weiler I J, Schuler A, et al. Rearrangement of antigen receptor genes is defective in mice with severe combined immunodeficiency. Cell 1986, 46: 963
Gritsch HA, Glaser RM, Emery DW, et al. The importance of non-immune factors in reconstitution by discordant xenogeneic hematopoietic cells. Transplantation 1994, 57: 906
Emery DW, Sykes M, Sachs DH, LeGuern C. Mixed swine/human long-term bone marrow cultures. Transplant Proc 1994, 26: 1313
Yang Y-G, Sergio JJ, Swenson K, Glaser RM, Monroy R, Sykes M. Donor-specific growth factors promote swine hematopoiesis in SCID mice. Xenotransplantation 1996, 3: 92
Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomologous monkeys. Transplantation 1995, 59: 256
Latinne D, Gianello P, Smith CV, et al. Xenotransplantation from pig to cynomolgus monkey: An approach toward tolerance induction. Transplant Proc 1993, 250: 336
McDermott WV, Norman JC. Extracorporeal pig liver perfusion in the treatment of hepatic coma. Epatologia 1972, 18: 265
Collins BH, Chari RS, Magee JC, et al. Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure. Transplantation 1994, 58: 1162
Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993, 56: 1433
Sandrin MS, McKenzie IF. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev 1994, 141: 169
Alexandre G P J, Gianello P, Latinne D, et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy M A, ed. Excerpta Medica, New York, 1989: 259
Alexandre GP, Squifflet JP, De Bruyere M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987, 19: 4538
Thomas FT, Tepper MA, Thomas JM, Haisch CE. 15-Deoxyspergualin: a novel immunosuppressive drug with clinical potential. Ann NY Acad Sei 1993, 685: 175
Tanaka M, Latinne D, Gianello P, et al. Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism. Transplant Proc 1994, 26: 1326
Sharabi Y, Abraham VS, Sykes M, Sachs DH. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant 1992, 9: 191
Khan A, Tomita Y, Sykes M. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 1996,62: 380
Lee LA, Gritsch HA, Sergio JJ, et al. Specific tolerance across a discordant xenogeneic transplantation barrier. Proc Natl Acad Sei USA 1994, 91: 10864
Zhao Y, Swenson K, Sergio JJ, Arn JS, Sachs DH, Syker M. Skin graft tolerance across a discordant xenogeneic barrier. Nature Med 1996, 2: 1211
Speiser DE, Pircher H, Ohashi PS, Kyburz D, Hengartner H, Zinkernagel RM. Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny. J Exp Med 1992,175: 1277
Salaun J, Bandeira A, Khazaal I, et al. Thymic epithelium tolerizes for histocompatibility antigens. Science 1990, 247: 1471
Gao E-K, Lo D, Sprent J. Strong T cell tolerance in parent→ F1 bone marrow chimeras prepared with supralethal irradiation. J Exp Med 1990, 171: 1101
Bonomo A, Matzinger P. Thymus epithelium induces tissue-specific tolerance. J Exp Med 1993, 177: 1153
Ramsdell F, Lantz T, Fowlkes BJ. A nondeletional mechanism of thymic self tolerance. Science 1989, 246: 1038
Bradley SM, Kruisbeek AM, Singer A. Cytotoxic T lymphocyte response in allogeneic radiation bone marrow chimeras. The chimeric host strictly dictates the self-repertoire of la-restricted T cells but not K/D-restricted T cells. J Exp Med 1982, 156: 1650
Geha RS, Rosen FS. The evolution of MHC restrictions in antigen recognition by T cells in a haploidentical bone marrow transplant recipient. J Immunol 1989, 143: 84
Chu E, Umetsu D, Rosen F, Geha RS. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation. J Clin Invest 1983, 72: 1124
Roncarolo MG, Yssel H, Touraine J-L, et al. Antigen recognition by MHC-incompatible cells of a human mismatched chimera. J Exp Med 1988, 168: 2139
Kollman TR, Goldstein MM, Goldstein H. The concurrent maturation of mouse and human thymocytes in human fetal thymus implanted in NIH-biege-nude-xid mice is associated with reconstitution of the murine immune system. J Exp Med 1993, 177: 821
Bevan MJ, Fink PJ. The influence of thymus H-2 antigens on the specificity of maturing killer and helper cells. Immunol Rev 1978, 42: 3
Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995, 332: 143
Annett G, Weinberg K, Kashyap A, et al. Post-transplantation thymic function predicts immunocompetence. Blood 1994, 84: 250a.(Abstrac1t)
Stanley SK, McCune JM, Kaneshima H, et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993, 178: 1151
Grody WW, Fligiel S, Naeim F. Thymus involution in the acquired immunodeficiencysyndrome. Am J Clin Pathol 1985, 84: 85
Kollman TR, Kim A, Pettoello-Mantovani M, et al. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. J Immunol 1995, 154: 907
Schuurman H-J, Krone WJA, Broekhuizen R, et al. The thymus in acquired immune deficiency syndrome. Comoparison with other types of immunodeficiency diseases, and presence of components of human immunodeficiency virus type 1. Am J Pathol 1989, 134: 1329
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sykes, M., Sachs, D.H. (1997). Xenogeneic Tolerance Through Hematopoietic Cell and Thymic Transplantation. In: Cooper, D.K.C., Kemp, E., Platt, J.L., White, D.J.G. (eds) Xenotransplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60572-7_38
Download citation
DOI: https://doi.org/10.1007/978-3-642-60572-7_38
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64460-3
Online ISBN: 978-3-642-60572-7
eBook Packages: Springer Book Archive